SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Apr-24 4:55 PM View: | Kinnate Biopharma Inc. (KNTE) | 03-Apr-24 | Disposition | 66,377 | -- | -- | (100%) 66.38K to 0 | |
15-Feb-19 9:11 AM View: | Loxo Oncology, Inc. (LOXO) | 15-Feb-19 | Disposition | 9,732 | $235.00 | $2,287,020.00 | (100%) 9.73K to 0 | < 1% |
11-Jun-18 6:00 PM View: | Loxo Oncology, Inc. (LOXO) | 07-Jun-18 | Option Exercise | 50,000 | $1.18 | $59,200.00 | 514% 9.73K to 59.73K | |
11-Jun-18 6:00 PM View: | Loxo Oncology, Inc. (LOXO) | 07-Jun-18 | Market Option Sale | 50,000 | $173.54 | $8,677,030.00 | (84%) 59.73K to 9.73K | (35%) |
22-Nov-17 5:05 PM View: | Loxo Oncology, Inc. (LOXO) | 20-Nov-17 | Market Sale (Planned) | 7,250 | $75.99 | $550,921.00 | (43%) 16.98K to 9.73K | (209%) |
23-Aug-17 6:33 PM View: | Loxo Oncology, Inc. (LOXO) | 21-Aug-17 | Market Sale (Planned) | 7,250 | $72.26 | $523,883.00 | (30%) 24.23K to 16.98K | (225%) |
24-May-17 4:02 PM View: | Loxo Oncology, Inc. (LOXO) | 22-May-17 | Market Sale (Planned) | 7,250 | $45.09 | $326,936.00 | (23%) 31.48K to 24.23K | (420%) |
23-Feb-17 4:34 PM View: | Loxo Oncology, Inc. (LOXO) | 21-Feb-17 | Market Sale (Planned) | 7,250 | $41.45 | $300,517.00 | (19%) 38.73K to 31.48K | (466%) |
21-Dec-16 5:30 PM View: | Loxo Oncology, Inc. (LOXO) | 19-Dec-16 | Market Sale (Planned) | 7,250 | $30.23 | $219,168.00 | (16%) 45.98K to 38.73K | (651%) |
09-Sep-16 4:34 PM View: | Loxo Oncology, Inc. (LOXO) | 07-Sep-16 | Market Sale (Planned) | 14,500 | $30.00 | $435,000.00 | (24%) 60.48K to 45.98K | (635%) |
12-Aug-16 5:05 PM View: | Loxo Oncology, Inc. (LOXO) | 11-Aug-16 | Market Sale (Planned) | 15,000 | $26.00 | $389,967.00 | (20%) 75.48K to 60.48K | (749%) |